Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Schultz

Showing results (61-70 of 310) with videos related to

Pageof 31
Sort By:
Cancer Discovery|June 22, 2026
Deconvolving SARS-CoV-2 mRNA vaccine impact on immunotherapy-related survivalJustin Jee, Jiajia Zhang, Jessica A Lavery, et al.
Cancer Discovery|May 15, 2015
Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skippingPaul K Paik, Alexander Drilon, Pang-Dian Fan, et al.
Molecular Oncology|May 10, 2020
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancerYing Z Mazzu, Joshua Armenia, Subhiksha Nandakumar, et al.
The Journal of Pathology|August 18, 2012
MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapesLawrence A Donehower, Chad J Creighton, Nikolaus Schultz, et al.
Oncogene|August 16, 2024
Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitorsAradhya Nigam, Gnana P Krishnamoorthy, Walid K Chatila, et al.
NPJ Precision Oncology|May 14, 2025
Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancersSoufyan Lakbir, Renske de Wit, Ino de Bruijn, et al.
Science Signaling|April 4, 2013
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortalJianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, et al.
Genome Medicine|January 25, 2017
3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targetsJianjiong Gao, Matthew T Chang, Hannah C Johnsen, et al.
Cancer Discovery|February 14, 2012
Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomasBarry S Taylor, Penelope L DeCarolis, Christina V Angeles, et al.
Nature Genetics|March 25, 2014
Recurrent SMARCA4 mutations in small cell carcinoma of the ovaryPetar Jelinic, Jennifer J Mueller, Narciso Olvera, et al.
Pageof 31

Showing results (61-70 of 310) with videos related to

Sort By:
Pageof 31
Cancer Discovery|June 22, 2026
Deconvolving SARS-CoV-2 mRNA vaccine impact on immunotherapy-related survivalJustin Jee, Jiajia Zhang, Jessica A Lavery, et al.
Cancer Discovery|May 15, 2015
Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skippingPaul K Paik, Alexander Drilon, Pang-Dian Fan, et al.
Molecular Oncology|May 10, 2020
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancerYing Z Mazzu, Joshua Armenia, Subhiksha Nandakumar, et al.
The Journal of Pathology|August 18, 2012
MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapesLawrence A Donehower, Chad J Creighton, Nikolaus Schultz, et al.
Oncogene|August 16, 2024
Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitorsAradhya Nigam, Gnana P Krishnamoorthy, Walid K Chatila, et al.
NPJ Precision Oncology|May 14, 2025
Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancersSoufyan Lakbir, Renske de Wit, Ino de Bruijn, et al.
Science Signaling|April 4, 2013
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortalJianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, et al.
Genome Medicine|January 25, 2017
3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targetsJianjiong Gao, Matthew T Chang, Hannah C Johnsen, et al.
Cancer Discovery|February 14, 2012
Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomasBarry S Taylor, Penelope L DeCarolis, Christina V Angeles, et al.
Nature Genetics|March 25, 2014
Recurrent SMARCA4 mutations in small cell carcinoma of the ovaryPetar Jelinic, Jennifer J Mueller, Narciso Olvera, et al.
Pageof 31